Ozurdex 2.0: The Game Has Changed

Show Description +

Michael Singer, MD, and Joshua Singer of the Medical Center Ophthalmology Associates in San Antonio, Texas demonstrates the new, sharper needle for the Ozurdex (dexamethasone intravitreal implant) 0.7 mg injection system. It compares it to the original needle, and shows how the new needle changes the experience for the patient, the staff and the doctor. To view the original video, click here.

Posted: 12/04/2012

Ozurdex 2.0: The Game Has Changed

Michael Singer, MD, and Joshua Singer of the Medical Center Ophthalmology Associates in San Antonio, Texas demonstrates the new, sharper needle for the Ozurdex (dexamethasone intravitreal implant) 0.7 mg injection system. It compares it to the original needle, and shows how the new needle changes the experience for the patient, the staff and the doctor. To view the original video, click here.

Posted: 12/04/2012

Please log in to leave a comment.

More in Retina

Staining Under Air

Frédéric Aissani, MD

Assessing Surgical Competency Among Retina Fellows: Perspectives from Directors and Graduates

Nikisha Kothari, MD; Jesse Sengillo, MD; and Nicholas Farber, MD

Anti-VEGF for Proliferative Sickle Cell Retinopathy

Maria Berrocal, MD and Jennifer Lim, MD

Spotlight on UNITY® VCS: UNITY for All

Sarwar Zahid, MD, FASRS; John W. Kitchens, MD; and Matthew A. Cunningham, MD, FASRS